What is Dms?
Long Beach Clinical Trials, operating under the Dms umbrella, specializes in providing state-of-the-art technology and integrated systems for clinical trials. Their services are engineered to ensure flexibility, transparency, and efficiency in trial management through expertly designed components. The company aims to support clients, including researchers and organizations involved in clinical studies, with a comprehensive portfolio of clinical trial technology tailored to meet specific requirements, thereby enhancing the reliability and efficiency of trial management solutions.
How much funding has Dms raised?
Dms has raised a total of $36K across 1 funding round:
Debt
$36K
Debt (2021): $36K with participation from PPP
Key Investors in Dms
PPP
Public-Private Partnership
What's next for Dms?
With the recent influx of substantial expansion capital, Dms is poised for significant scaling and operational enhancement. The company's focus on advanced technology for clinical trials suggests strategic investments in R&D, market penetration, and potentially expanding its service offerings to a broader client base. This financing round is indicative of strong investor confidence in Dms's business model and its capacity to innovate within the competitive clinical trial technology sector.
See full Dms company page
